Francesco Lanza is Director of the Hematology Unit and Romagna Metropolitan Transplant Network. He acts as Subcommittee chair of the Acute Leukemia Working Party of the European Transplantation Society EBMT (2018-today), president of the Italian Society for Apheresis and Manipulation for Cellular Therapy (GIIMA) (2018-today), Associate Editor for Cytometry part B (Chicago, US, 2007- present), senior Editor of Transfusion and Apheresis Science Journal (US) 2018-today, executive board member of GITMO and Sidem Italian Societies. Past Chairman of the “Solid Tumor Working Party” of European Blood and Marrow Transplantation Society (2013-2017), Past President of the International Society for Cell therapy (ISCT)- European Branch (2009-2012), past Member of CAT (Committee for Advanced Therapy) at EMA (European Medical Agency) (2010 2012), Past President of the Italian Society of Cytometry GIC (2008-2012). He is author of > 300 original papers in international Journals (Impact Factor > 1300, H index 39), 42 review articles or editorials, editor for 15 books (English text), 75 chapters from books, and 110 Italian papers. His main research activity focuses on stem cell transplantation, acute leukemia, and stem cell processing.